These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 3501473

  • 1. Penicillamine induced polymyositis and dermatomyositis.
    Carroll GJ, Will RK, Peter JB, Garlepp MJ, Dawkins RL.
    J Rheumatol; 1987 Oct; 14(5):995-1001. PubMed ID: 3501473
    [Abstract] [Full Text] [Related]

  • 2. [D-penicillamine-induced myasthenia gravis].
    Frey RA, Keller F, Michel BA.
    Schweiz Med Wochenschr; 1994 May 21; 124(20):852-6. PubMed ID: 8209208
    [Abstract] [Full Text] [Related]

  • 3. [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
    Rodat O, Hamelin JP, Rossard A, Cottin S, Cler JM, Rodat G, Lemouroux P.
    Nouv Presse Med; 1981 May 02; 10(20):1645-8. PubMed ID: 7255126
    [Abstract] [Full Text] [Related]

  • 4. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A, Newsom-Davis J.
    Clin Exp Immunol; 1982 Aug 02; 49(2):266-72. PubMed ID: 7127905
    [Abstract] [Full Text] [Related]

  • 5. [Polymyositis induced by D-penicillamine treatment of rheumatoid arthritis: apropos of 2 cases with antinuclear antibodies].
    Masson CJ, Ménard HA, Audran M, Renier JC, Lussier A, Myhal DM.
    Union Med Can; 1986 Dec 02; 115(12):855-9. PubMed ID: 3492802
    [No Abstract] [Full Text] [Related]

  • 6. Neuromuscular disorders associated with D-penicillamine treatment for rheumatoid arthritis.
    Devogelaer JP, Isaac G, Noël H, De Bruyère M, Huaux JP, Nagant de Deuxchaisnes C.
    Int J Clin Pharmacol Res; 1985 Dec 02; 5(3):143-7. PubMed ID: 4018948
    [Abstract] [Full Text] [Related]

  • 7. [Acetylcholine receptor antibody in D-penicillamine therapy].
    Kolarz G, Maida EM.
    Z Rheumatol; 1986 Dec 02; 45(3):118-21. PubMed ID: 3751350
    [Abstract] [Full Text] [Related]

  • 8. [Neuromuscular complications of D-penicillamine in rheumatoid arthritis].
    Dubost JJ, Soubrier M, Bouchet F, Kemeny JL, Lhopitaux R, Bussière JL, Sauvezie B.
    Rev Neurol (Paris); 1992 Dec 02; 148(3):207-11. PubMed ID: 1604135
    [Abstract] [Full Text] [Related]

  • 9. D-penicillamine-induced myasthenia gravis in primary biliary cirrhosis.
    Marcus SN, Chadwick D, Walker RJ.
    Gastroenterology; 1984 Jan 02; 86(1):166-8. PubMed ID: 6689658
    [Abstract] [Full Text] [Related]

  • 10. Fine antigenic specificities of antibodies in sera from patients with D-penicillamine-induced myasthenia gravis.
    Tzartos SJ, Morel E, Efthimiadis A, Bustarret AF, D'Anglejan J, Drosos AA, Moutsopoulos HA.
    Clin Exp Immunol; 1988 Oct 02; 74(1):80-6. PubMed ID: 2464451
    [Abstract] [Full Text] [Related]

  • 11. [Myasthenia induced by D-penicillamine. Study of immuno-clinical correlations in 23 cases].
    d'Anglejan J, Morel E, Feuillet-Fieux MN, Raimond F, Vernet der Garabedian B, Jacob L, Bach JF.
    Presse Med; 1985 Dec 28; 14(46):2336-40. PubMed ID: 2935832
    [Abstract] [Full Text] [Related]

  • 12. [Myasthenia induced by D-penicillamine. Apropos of 2 case reports].
    Huaux JP, Delreux V.
    Acta Neurol Belg; 1986 Dec 28; 86(5):297-303. PubMed ID: 3492852
    [Abstract] [Full Text] [Related]

  • 13. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
    Garlepp MJ, Dawkins RL, Christiansen FT.
    Br Med J (Clin Res Ed); 1983 Jan 29; 286(6362):338-40. PubMed ID: 6402089
    [Abstract] [Full Text] [Related]

  • 14. [Myasthenia induced by D-penicillamine during the treatment of rheumatoid polyarthritis].
    Carter H, Job-Deslandre C, Delrieu F, Kahan A, Menkès CJ.
    Rev Rhum Mal Osteoartic; 1986 May 29; 53(5):341-4. PubMed ID: 3738397
    [Abstract] [Full Text] [Related]

  • 15. [Dermatopolymyositis induced by D-penicillamine in rheumatoid polyarthritis. Apropos of 1 case with review of the literature].
    Kolsi R, Bahloul Z, Hachicha J, Gouiaa R, Jarraya A.
    Rev Rhum Mal Osteoartic; 1992 May 29; 59(5):341-4. PubMed ID: 1411195
    [Abstract] [Full Text] [Related]

  • 16. Autoantibodies in D-penicillamine-induced myasthenia gravis: a comparison with idiopathic myasthenia and rheumatoid arthritis.
    Morel E, Feuillet-Fieux MN, Vernet-der Garabedian B, Raimond F, D'Anglejan J, Bataille R, Sany J, Bach JF.
    Clin Immunol Immunopathol; 1991 Mar 29; 58(3):318-30. PubMed ID: 2001604
    [Abstract] [Full Text] [Related]

  • 17. D-Penicillamine-associated myasthenia gravis: immunological and electrophysiological studies.
    Fawcett PR, McLachlan SM, Nicholson LV, Argov Z, Mastaglia FL.
    Muscle Nerve; 1982 Apr 29; 5(4):328-34. PubMed ID: 7099199
    [Abstract] [Full Text] [Related]

  • 18. Penicillamine-induced ocular myasthenia gravis in rheumatoid arthritis.
    Liu GT, Bienfang DC.
    J Clin Neuroophthalmol; 1990 Sep 29; 10(3):201-5. PubMed ID: 2144538
    [Abstract] [Full Text] [Related]

  • 19. [Myasthenia gravis syndrome following administration of d-penicillamine (author's transl)].
    Rousseau JJ, Dieudonne LG.
    Acta Neurol Belg; 1980 Sep 29; 80(3):165-73. PubMed ID: 7457085
    [Abstract] [Full Text] [Related]

  • 20. [Myasthenia during treatment of rheumatoid polyarthritis with D-penicillamine].
    Carter H, Job-Deslandre C, Delrieu F, Menkes CJ.
    Therapie; 1984 Sep 29; 39(6):689-95. PubMed ID: 6531741
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.